Zobrazeno 1 - 10
of 213
pro vyhledávání: '"Dmard therapy"'
Publikováno v:
Журнал инфектологии, Vol 13, Iss 2, Pp 44-52 (2021)
Introduction. The issue of protection against vaccinepreventable diseases has acquired new urgency in connection with the decrease in the vaccination rate established by WHO against the background of the COVID-19 pandemic. This creates the conditions
Externí odkaz:
https://doaj.org/article/edcd5356c604467dbb55b35870afc0a1
Autor:
O.B. Iaremenko
Publikováno v:
Медична наука України, Vol 17, Iss 2, Pp 59-69 (2021)
Relevance. Achieving remission is one of the main goals in the treatment of patients with rheumatoid arthritis (RA). One of the determining predictors of the disease, according to the literature, is the serological variant of RA. However, there are c
Externí odkaz:
https://doaj.org/article/a5085e34b8cb4adbac612963a3937fb1
Publikováno v:
Arthritis Care & Research. 74:1903-1908
Objective To integrate an auto-notification system into clinical workflow, so timely communication of sentinel events (elective surgery, hospital admission, or ER visit) in immunosuppressed rheumatic disease patients happened by design. Methods We de
Publikováno v:
rheuma plus. 20:267-271
Since the first case of coronavirus infection with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and the associated COVID-19 (corona virus disease 2019) it has become a worldwide pandemic. This leads to persistent and far-reaching cons
Autor:
Klaus Krüger, Martin Feuchtenberger, Monika Ronneberger, H. Nuesslein, David Simon, Koray Tascilar, Axel J. Hueber, Juergen Rech, Hanns-Martin Lorenz, Michaela Reiser, Martin Fleck, Hans-Peter Tony, Rieke Alten, M. Schmitt-Haendle, Camille P. Figueiredo, Joerg Wendler, Wolfgang Ochs, Jayme Fogagnolo Cobra, F. Schuch, K. Manger, Georg Schett, Bernhard Manger, Matthias Englbrecht, Stefan Kleinert, Stephanie Finzel, Melanie Hagen, Joerg Henes, Arnd Kleyer
Publikováno v:
The Lancet Rheumatology. 3:e767-e777
Summary Background Owing to increasing remission rates, the management of patients with rheumatoid arthritis in sustained remission is of growing interest. The Rheumatoid Arthritis in Ongoing Remission (RETRO) study investigated tapering and withdraw
Publikováno v:
Žurnal Infektologii, Vol 13, Iss 2, Pp 44-52 (2021)
Introduction. The issue of protection against vaccinepreventable diseases has acquired new urgency in connection with the decrease in the vaccination rate established by WHO against the background of the COVID-19 pandemic. This creates the conditions
Autor:
G.M. Mykytenko, O.B. Iaremenko
Publikováno v:
Медична наука України, Vol 17, Iss 2, Pp 59-69 (2021)
Relevance. Achieving remission is one of the main goals in the treatment of patients with rheumatoid arthritis (RA). One of the determining predictors of the disease, according to the literature, is the serological variant of RA. However, there are c
Autor:
Elena Szefer, Cheryl Barnabe, Vivian P. Bykerk, Claire E.H. Barber, Deborah A. Marshall, Marinka Twilt, Diane Lacaille, Natalie J. Shiff, Dianne Mosher, Joanne Homik, J. Carter Thorne, Vandana Ahluwalia, Susanne M. Benseler
Publikováno v:
Arthritis Care & Research. 73:640-648
OBJECTIVE To operationalize and report on nationally endorsed rheumatoid arthritis (RA) performance measures (PMs) using health administrative data for British Columbia (BC), Canada. METHODS All patients with RA in BC ages ≥18 years were identified
Autor:
Costantino Pitzalis, Esteban A. Gomez, Conrad Bessant, Romain A. Colas, Rebecca Hands, Myles Lewis, Patricia R. Souza, Jesmond Dalli
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-13 (2020)
Nature Communications
Nature Communications
Biomarkers are needed for predicting the effectiveness of disease modifying antirheumatic drugs (DMARDs). Here, using functional lipid mediator profiling and deeply phenotyped patients with early rheumatoid arthritis (RA), we observe that peripheral
Publikováno v:
Rheuma plus
Seit dem ersten Fall einer Infektion mit SARS‐CoV‐2 („severe acute respiratory syndrome coronavirus 2“) und der damit assoziierten COVID-19-Erkrankung („corona virus disease 19“) existiert eine weltweite Pandemie. Diese führt zu anhalten